Modify your box, pause or cancel anytime
Obesity and Cancer: A Current Overview of Epidemiology, Pathogenesis, Outcomes, and Management
The medication works by mimicking the action of two naturally occurring incretin hormones: GIP and GLP-1
Robert Gabbay, MD, PhD, Chief Scientific and Medical Officer Possible Side Effects The safety profile of Retatrutide is still being characterized through clinical trials
As I was writing this article (Feb 27, ~5:45 AM EST), I reached out to him for clarification either to provide an updated or corrected comment, or to point me toward data I may be overlooking (which is entirely possible)
This simply means it mimics two incretin hormones instead of just GLP-1